Immunic, Inc. IMUX
7.33 USD +0.10 (+1.38%)
Regular-session close
7.55 +0.22 +2.95%
After hours · Nov 17, 4:16 PM ET
7.06 Day range 7.48
5.06 52-week range 17.43
- YTD
- +37.27%
- 1 year
- +0.41%
News
benzinga.com Immunic Q3 EPS $(0.99) Misses $(0.96) Estimate Immunic (NASDAQ:IMUX) reported quarterly losses of $(0.99) per share which missed the analyst consensus estimate of $(0.96) by 3.13 percent. This is a 25 percent increase over losses of $(1.32) per…
prnewswire.com Immunic, Inc. Reports Third Quarter 2026 Financial Results and Provides Corporate Update – Pivotal Phase 3 ENSURE-1 and ENSURE-2 Trials of Vidofludimus Calcium in Relapsing Multiple Sclerosis Remain on Track, with Top-Line Data Expected in December 2026 – – Initiation of Phase 3…benzinga.com Cantor Fitzgerald Initiates Coverage On Immunic with Overweight Rating Cantor Fitzgerald analyst Yanni Souroutzidis initiates coverage on Immunic (NASDAQ:IMUX) with a Overweight rating.
